The report of the global anti-snoring devices market by Type (Oral Appliances, Nasal Devices, Position Control Devices, Chin Straps, Tongue-stabilizing Devices, Expiratory Positive Airway Pressure (EPAP) Therapy Devices), End User (Hospitals, Community Healthcare, Sleep Clinics, Home Healthcare, Others) Region (North America, Europe, Middle East & Africa, South America, Asia Pacific) is expected to reach US$ 24.9 Bn. by 2027, at a CAGR of 3.91% during a forecast period.
The upward push in cases of obesity and sleep issues across the world is growing the demand for snoring devices. The growing demand is promising significant players to make investments for technology advancements.
The Expiratory positive airway pressure (EPAP) devices segment is expected to grow at the highest CAGR of XX% during the forecast period.
The expiratory positive airway pressure segment was valued at USD XX Mn. in 2019 and is expected to reach USD XX Mn. by 2027. Expiratory positive airway pressure (EPAP) devices enable straightforward breathing whereas sleeping, particularly in people suffering from obstructive apnea and snoring. These devices upsurge air pressure in throat to avoid airway collapse while breathing.
North America dominated the Global Anti-snoring Devices Market in 2019.
The market in North America is projected to lead the global anti-snoring devices market in terms of revenue through the forecast duration, thanks to new technology which are invariably being developed concerning the market, the analysis of these snoring sicknesses has been effective and treatments are showing to be more helpful to patients. Therefore, the increasing attention between patients regarding the effectiveness of anti-snoring devices, and the smooth available of advanced detective work approaches throughout the globe, are resulting within the raised demand for anti- snoring devices.
The key players operating in the global Anti-snoring Devices market are Hivox Biotek Inc., Sleep Well Enjoy Life Ltd, Sleeping Well LLC, Meditas, ZYPPAH, Tomed GmbH, Rhinomed Ltd, GlaxoSmithKline plc, Apnea Sciences Corporation, SomnoMed Ltd., Theravent, MPowerx.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the Global Anti-snoring Devices Market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the Global Anti-snoring Devices Market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain Global Anti-snoring Devices Market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Anti-snoring Devices Market”
https://www.maximizemarketresearch.com/market-report/global-anti-snoring-devices-market/62113/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908